
| Asbestos Mesothelioma Lung Cancer Guide - Get advice on asbestos and mesothelioma help, symptoms, treatment exposure, legal options like lawyers, attorney & lawsuits. |
![]() |
|
|
Home :: Cancer Medicines and Drugs ::
Irinotecan
IrinotecanIrinotecan inhibits topoisomerase I, can enzyme involved in DNA replication. Indications: Metastatic carcinoma of the colon or rectum when disease has progressed or recurred following 5-FU therapy. Dosage of Irinotecan hydrochlorideVaries in weekly and once every three week schedule. All dosages are to be administered as IV infusion over 90 minutes. Weekly dose schedule: The usual starting dose is 125mg/m2; patients should be carefully monitored for toxicity. Subsequent doses may be adjusted to as high as 150mg/m2. Once every three weeks dosage schedule: The usual starting dose is 350mg/m2; patients should be carefully monitored for toxicity. Subsequent doses may be adjusted to as low as 200mg/m2. Contralndlcations -- Known hypersensitivity to irinotecan. Side effects fo Irinotecan hydrochloride
Drug Interactions of Irinotecan hydrochlorideOther antineoplastic agents -- Side effects like diarrhoea and myelosuppression may be exacerbated. Dexamethasone -- Lymphocytopenia has been observed when coadministered. Diuretics -- Because of possibiilty of causing dehydration with diarrhoea, caution should be observed in the use of irinotecan with diuretics.
|
||||||||||||||||||